Pharmacokinetics and pharmacodynamics of Levofloxacin against Streptococcus pneumoniae and Staphylococcus aureus in human skin blister fluid

Andrej Trampuz, Markus Wenk, Zarko Rajacic, Werner Zimmerli*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

29 Citations (Scopus)

Abstract

The pharmacokinetics of levofloxacin in serum and in skin blister fluid (SBF) was determined for 20 volunteers after a single 500-mg oral dose of levofloxacin. In addition, ex vivo bactericidal activity of SBF against Streptococcus pneumoniae and Staphylococcus aureus was studied. SBF containing levofloxacin and granulocytes killed 5.2 log of Streptococcus pneumoniae bacteria and 2.0 log of Staphylococcus aureus bacteria during a 6- h incubation.

Original languageEnglish
Pages (from-to)1352-1355
Number of pages4
JournalAntimicrobial Agents and Chemotherapy
Volume44
Issue number5
DOIs
Publication statusPublished - May 2000
Externally publishedYes

Fingerprint

Dive into the research topics of 'Pharmacokinetics and pharmacodynamics of Levofloxacin against Streptococcus pneumoniae and Staphylococcus aureus in human skin blister fluid'. Together they form a unique fingerprint.

Cite this